Skip to main content
Premium Trial:

Request an Annual Quote

Devgen Creates C. elegans RNA Interference Library

NEW YORK, Feb. 22 - Belgian functional genomics company Devgen on Friday said it has created a complete C. elegans RNA interference library.

The library is genome-wide, including complexes that can suppress the activity of each of the 19,000 C. elegans genes. Devgen plans to use the library in drug-target identification and functional validation.

 

RNAi is a form of post-transcriptional gene silencing that works by targeting and cleaving endogenous mRNA.

 

Devgen, based in Ghent, uses C. elegans as a model for target and drug discovery. It uses RNAi knockdown technology in the worm to evaluate gene function, and combines that technique with a comparative-genomics approach to understand human homologues of disease pathways.

 

The company, which employs about 90 people, is privately held. It has partnerships with Princeton, NJ-based  FMC Corp. for new pesticide discovery, and with Metabolex for diabetes research.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.